Rasburicase
RxNorm 283821
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 283821 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Rasburicase.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
FNPrescribable
Full form of descriptor (FN):
Product containing rasburicase (medicinal product)
(Atom ID: 9731386)
INPrescribable
Ingredient (IN):
Rasburicase
(Atom ID: 12251180)
PTPrescribable
Designated preferred name (PT):
Rasburicase
(Atom ID: 1355570)
FNPrescribable
Full form of descriptor (FN):
Rasburicase (substance)
(Atom ID: 1355572)
PTPrescribable
Designated preferred name (PT):
Rasburicase-containing product
(Atom ID: 10820141)
PTPrescribable
Designated preferred name (PT):
Recombinant urate oxidase
(Atom ID: 2066664)
FNPrescribable
Full form of descriptor (FN):
Recombinant urate oxidase (substance)
(Atom ID: 2066665)
Patient Education
Rasburicase Injection
Rasburicase injection is used to treat high levels of uric acid (a natural substance that builds up in the blood as tumors break down) in people with certain types of cancer who are being treated with chemotherapy medications. Rasburicase injection is in a class of medications called enzymes. It works by breaking down uric acid so that the body can eliminate it.
[Learn More]
* Please review the disclaimer below.